Love for country moves differently-abled Emirati to take part in COVID-19 vaccine trial - GulfToday

Love for country moves differently-abled Emirati to take part in COVID-19 vaccine trial

Ahmed-Mohamed-Al-Shaibani

Ahmed Mohamed Al Shaibani participates in the extremely important phase III trial of the COVID-19 inactivated vaccine.

Gulf Today, Staff Reporter

His passion, patriotism, and loyalty to his country encouraged Ahmed Mohamed Al Shaibani, a Senior Call Centre Officer at Al Ain Hospital (part of Seha), to participate in the extremely important phase III trial of the COVID-19 inactivated vaccine. To serve the country and its people, he was quick to respond to the nation’s call to volunteer for the trial.

To deliver on the vision of the UAE’s leadership and its commitment to combating the global epidemic, Seha is currently carrying out Phase III of new clinical trials of the COVID-19 inactivated vaccine, under the supervision of Health of Department - Abu Dhabi, G42 healthcare company, a subsidiary of the G42 Group.


READ MORE

WHO wants to review Russian vaccine safety data

India reports record number of new infections

UAE reports 435 new coronavirus cases in 24 hours conducts 72026 tests


Ahmed has always been an active volunteer for any project that serves the community and once he learned about the ongoing clinical trial of COVID-19 vaccine, he was one of the first ones to contribute to the initiative, which not only is going to benefit the UAE but the whole humanity.

Vaccine
The Phase III clinical trial of COVID-19 vaccine. 

On his participation, Al Shaibani expressed his happiness in being able to contribute to community service and overcoming a new challenge, despite his disability.

He also requested all People of Determination to get involved and play an integral role in the country’s progress. He also encouraged all community members to participate in the clinical trials, as each and everyone’s involvement matters to find the most effective COVID-19.

“Involvement of all society members in such clinical trials is a national duty,” Ahmed stressed. “The UAE community of citizens and residents never fails to respond to the appeal of the nation; I still remember when everyone chanted the national anthem of the UAE during the National Sterilisation Programme, to express their commitment and responsibility towards the nation,” he said.

Ahmed Al Shaibani has been working in Al Ain Hospital for nearly 20 years. He is dedicated to his work. Although as a Person of Determination, Ahmed has been exempted by law from coming to the workplace due to COVID -19 restrictions, he attends office every day and strictly adheres to the precautionary and preventive measures put in place by the organisation. As an active volunteer, Al Shaibani always requests his department to nominate him in any volunteering activity, especially any activity related to COVID-19. In addition, he is an active athlete, playing in the Emirates National Team at Al Ain Sports and Cultural Club.

The Phase III clinical trial of COVID-19 vaccine, listed under the umbrella of the World Health Organisation (WHO), produced by (Cinopharm CNBG), is a result of the international cooperation efforts initiated by the Abu Dhabi government in line with the UAE government and healthcare authorities commitment to find a cure for the most significant challenge that humankind has ever witnessed in the 21st century.

Related articles